Today: 20 May 2026
Palantir (PLTR) stock slides 5.6% as insider sale notice surfaces — what to watch next week
4 January 2026
1 min read

Palantir (PLTR) stock slides 5.6% as insider sale notice surfaces — what to watch next week

NEW YORK, Jan 4, 2026, 13:28 ET — Market closed

  • Palantir ended Friday down about 5.6% at $167.86, lagging a near-flat Nasdaq session.
  • A post-close SEC filing showed officer Ryan D. Taylor filed a Form 144 to sell up to 12,000 shares under a 10b5-1 plan.
  • Markets reopen Monday with Jan. 9 U.S. jobs data and Jan. 13 CPI in focus; Palantir’s next results are penciled in for early February on earnings calendars.

Palantir Technologies Inc shares closed down about 5.6% on Friday at $167.86, their first session of 2026, after swinging from an early high near $183 to a low around $166.

Why this matters now: the selloff leaves Palantir starting the week under a spotlight as investors return from the holidays and reassess risk in high-growth software names alongside a heavy macro calendar. “The market is looking for direction,” said Matthew Maley, chief market strategist at Miller Tabak, as traders eye whether stocks break out of recent ranges. Reuters

The first full trading week also brings U.S. employment data on Jan. 9 and consumer inflation data on Jan. 13, both potential swing factors for interest-rate expectations that tend to drive sentiment toward growth stocks. Fed funds futures suggest little chance of a rate cut at the central bank’s late-January meeting, with roughly a 50% chance of a quarter-point cut in March, Reuters reported.

After Friday’s closing bell, an SEC filing showed Palantir officer Ryan Douglas Taylor filed a Form 144 — a notice used by insiders planning to sell stock under SEC Rule 144 — to sell up to 12,000 shares valued at about $2.13 million through Morgan Stanley Smith Barney. The form cited a 10b5-1 plan, a pre-set trading schedule that allows executives to sell shares automatically.

The same filing listed earlier sales in late November totaling 56,061 shares for about $9.1 million in gross proceeds, underscoring the steady stream of insider supply investors will weigh into Monday’s open.

Palantir, known for software that helps organizations analyze large data sets, has drawn outsized attention from traders because its shares have been prone to sharp moves when sentiment shifts on “AI trade” positioning and rate expectations.

For the next catalyst on the company side, Palantir last guided fourth-quarter revenue to $1.327 billion to $1.331 billion, according to a company statement, a bar investors will use to frame expectations heading into the next report.

But the downside case for the stock is straightforward: hotter inflation or firmer jobs data could push bond yields higher and squeeze richly valued growth shares, while additional insider filings can add to near-term supply just as liquidity returns after the holidays.

Earnings calendars on Nasdaq and Yahoo Finance currently point to Feb. 2 for Palantir’s next report, though the company has not posted an announced date on its investor events page.

Stock Market Today

  • Oil Prices Fall After Trump Comments on Ending Iran War
    May 20, 2026, 7:14 AM EDT. Oil prices declined on Tuesday following President Trump's statement reaffirming his intent to end the conflict with Iran "very quickly." The Strait of Hormuz, a critical chokepoint for global oil shipments, experienced one of its busiest days since its recent closure, underscoring the region's importance to energy markets and the potential impact of geopolitical developments on supply dynamics.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Tesco issues urgent “do not eat” recall for three pate lines after date-label error
Previous Story

Tesco issues urgent “do not eat” recall for three pate lines after date-label error

SOHO spots water gushing from interstellar comet 3I/ATLAS after its Sun pass
Next Story

SOHO spots water gushing from interstellar comet 3I/ATLAS after its Sun pass

Go toTop